| [1] |
Zheng W, Zhao S, Yin Y, et al. High－throughput, single－microbe genomics with strain resolution, applied to a human gut microbiome [J]. Science, 2022, 376(6597): 1483.
|
| [2] |
Vujkovic－Cvijin I, Sklar J, Jiang L, et al. Host variables confound gut microbiota studies of human disease [J]. Nature, 2020, 587(7834): 448-454.
|
| [3] |
Shulman ST, Friedmann HC, Sims RH. Theodor escherich: The first pediatric infectious diseases physician? [J]. Clin Infect Dis, 2007, 45(8): 1025-1029.
|
| [4] |
周晶晶，王志，付欣，等. 肠道菌群在疾病中的研究进展 [J]. 延安大学学报(医学科学版)，2020，18(2):93-96.
|
| [5] |
Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease [J]. Nat Neurosci, 2017, 20(2): 145-155.
|
| [6] |
Rinninella E, Raoul P, Cintoni M, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases [J]. Microorganisms, 2019, 7(1): e14.
|
| [7] |
Zmora N, Suez J, Elinav E. You are what you eat: Diet, health and the gut microbiota [J]. Nat Rev Gastroenterol Hepatol, 2019, 16(1): 35-56.
|
| [8] |
Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease [J]. Nat Neur, 2017, 20(2): 145-155.
|
| [9] |
Pane M, Amoruso A, Deidda F, et al. Gut microbiota, probiotics, and sport: From clinical evidence to agonistic performance [J]. J Clin Gastroenterol, 2018, 52(S1): s46-s49.
|
| [10] |
Doyle SL, Campbell M, Ozaki E, et al. Nlrp3 has a protective role in age－related macular degeneration through the induction of il－18 by drusen components [J]. Nat Med, 2012, 18(5): 791-798.
|
| [11] |
Richards JL, Yap YA, Mcleod KH, et al. Dietary metabolites and the gut microbiota: An alternative approach to control inflammatory and autoimmune diseases [J]. Clin Transl Immunol, 2016, 5(5): e82.
|
| [12] |
Verhaar BJH, Prodan A, Nieuwdorp M, et al. Gut microbiota in hypertension and atherosclerosis: A review [J]. Nutrients, 2020, 12(10): e2982.
|
| [13] |
Niu SY, Yang J, Mcdermaid A, et al. Bioinformatics tools for quantitative and functional metagenome and metatranscriptome data analysis in microbes [J]. Brief Bioinform, 2018, 19(6): 1415-1429.
|
| [14] |
Langille M, Zaneveld J, Caporaso J, et al. Predictive functional profiling of microbial communities using 16srRNA marker gene sequences [J]. Nat Biotechnol, 2013, 31(9): 814-821.
|
| [15] |
Zhao L. The gut microbiota and obesity: From correlation to causality [J]. Nat Rev Microbiol, 2013, 11(9): 639-647.
|
| [16] |
Psianou K, Panagoulias I, Papanastasiou AD, et al. Clinical and immunological parameters of Sjögren′s syndrome [J]. Autoimmun Rev, 2018, 17(10): 1053-1064.
|
| [17] |
Moon J, Yoon CH, Choi SH, et al. Can gut microbiota affect dry eye syndrome? [J]. Int J Mol Sci, 2020, 21(22): e8443.
|
| [18] |
Fujimura KE, Sitarik AR, Havstad S, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation [J]. Nat Med, 2016, 22(10): 1187-1191.
|
| [19] |
De－Paiva CS, Jones DB, Stern ME, et al. Altered mucosal microbiome diversity and disease severity in Sjögren syndrome [J]. Sci Rep, 2016, 6: e23561.
|
| [20] |
Cano－Ortiz A, Laborda－Illanes A, Plaza－Andrades I, et al. Connection between the gut microbiome, systemic inflammation, gut permeability and foxp3 expression in patients with primary Sjögren′s syndrome [J]. Int J Mol Sci, 2020, 21(22): e8733.
|
| [21] |
Mandl T, Marsal J, Olsson P, et al. Severe intestinal dysbiosis is prevalent in primary Sjögren′s syndrome and is associated with systemic disease activity [J]. Arthritis Res Ther, 2017, 19(1): e237.
|
| [22] |
Van－der－Meulen TA, Harmsen HJM, Vila AV, et al. Shared gut, but distinct oral microbiota composition in primary Sjögren′s syndrome and systemic lupus erythematosus [J]. J Autoimmun, 2019, 97: 77-87.
|
| [23] |
Watane A, Cavuoto KM, Rojas M, et al. Fecal microbial transplant in individuals with immune－mediated dry eye [J]. Am J Ophthalmol, 2021, 233: 90-100.
|
| [24] |
Yun SW, Son YH, Lee DY, et al. Lactobacillus plantarum and bifidobacterium bifidum alleviate dry eye in mice with exorbital lacrimal gland excision by modulating gut inflammation and microbiota [J]. Food Funct, 2021, 12(6): 2489-2497.
|
| [25] |
Bron AJ, De－Paiva CS, Chauhan SK, et al. TFOS DEWS Ⅱ pathophysiology report [J]. Ocul Surf, 2017, 15(3): 438-510.
|
| [26] |
Schaefer L, Hernandez H, Coats RA, et al. Gut－derived butyrate suppresses ocular surface inflammation [J]. Sci Rep, 2022, 12(1): 4512.
|
| [27] |
Yoon CH, Ryu JS, Moon J, et al. Association between aging－dependent gut microbiome dysbiosis and dry eye severity in C57BL/6 male mouse model: A pilot study [J]. BMC Microbiol, 2021, 21(1): 106.
|
| [28] |
Tellefsen NS, Badian RA, Utheim TP, et al. Sex and age differences in symptoms and signs of dry eye disease in a norwegian cohort of patients [J]. Ocul Surf, 2021, 19: 68-73.
|
| [29] |
He M, Foster PJ, Ge J, et al. Prevalence and clinical characteristics of glaucoma in adult chinese: A population－based study in liwan district, guangzhou [J]. Invest Ophthalmol Vis Sci, 2006, 47(7): 2782-2788.
|
| [30] |
Gong H, Zhang S, Li Q, et al. Gut microbiota compositional profile and serum metabolic phenotype in patients with primary open－angle glaucoma [J]. Exp Eye Res, 2020, 191: e107921.
|
| [31] |
Gong H, Zeng R, Li Q, et al. The profile of gut microbiota and central carbon－related metabolites in primary angle－closure glaucoma patients [J]. Int Ophthalmol, 2022, 42(6): 1927-1938.
|
| [32] |
Mcpherson ZE, Srensen HT, Horváth－Puhó E, et al. Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population－based cohort studies [J]. United European Gastroenterol J, 2021, 9(9): 1057-1065.
|
| [33] |
Tang J, Tang Y, Yi I, et al. The role of commensal microflora－induced T cell responses in glaucoma neurodegeneration [J]. Prog Brain Res, 2020, 256(1): 79-97.
|
| [34] |
Chen H, Cho KS, Vu THK, et al. Commensal microflora－induced T cell responses mediate progressive neurodegeneration in glaucoma [J]. Nat Commun, 2018, 9(1): 3209.
|
| [35] |
Xu H, Liu M, Cao J, et al. The dynamic interplay between the gut microbiota and autoimmune diseases [J]. J Immunol Res, 2019: 7546047.
|
| [36] |
Round JL, Mazmanian SK. Inducible foxp3+ regulatory T－cell development by a commensal bacterium of the intestinal microbiota [J]. PNAS USA, 2010, 107(27): 12204-12209.
|
| [37] |
Horai R, Caspi RR. Microbiome and autoimmune uveitis [J]. Front Immunol, 2019, 10: e232.
|
| [38] |
Asquith MJ, Stauffer P, Davin S, et al. Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis [J]. Arthritis Rheumatol, 2016, 68(9): 2151-2162.
|
| [39] |
Ye Z, Wu C, Zhang N, et al. Altered gut microbiome composition in patients with Vogt－Koyanagi－Harada disease [J]. Gut microbes, 2020, 11(3): 539-555.
|
| [40] |
Ye Z, Zhang N, Wu C, et al. A metagenomic study of the gut microbiome in Behcet′s disease [J]. Microbiome, 2018, 6(1): e135.
|
| [41] |
Zinkernagel MS, Zysset－Burri DC, Keller I, et al. Association of the intestinal microbiome with the development of neovascular age－related macular degeneration [J]. Sci Rep, 2017, 7: 40826.
|
| [42] |
Lin P. Importance of the intestinal microbiota in ocular inflammatory diseases: A review [J]. Clin Exp Ophthalmol, 2019, 47(3): 418-422.
|
| [43] |
Napolitano P, Filippelli M, Davinelli S, et al. Influence of gut microbiota on eye diseases: An overview [J]. Ann Med, 2021, 53(1): 750-761.
|
| [44] |
Mosher KI, Wyss－Coray T. Go with your gut: Microbiota meet microglia [J]. Nat Neurosci, 2015, 18(7): 930-931.
|
| [45] |
Andriessen EM, Wilson AM, Mawambo G, et al. Gut microbiota influences pathological angiogenesis in obesity－driven choroidal neovascularization [J]. EMBO Mol Med, 2016, 8(12): 1366-1379.
|
| [46] |
Gorusupudi A, Nelson K, Bernstein PS. The age－related eye disease 2 study: Micronutrients in the treatment of macular degeneration [J]. Adv Nutr, 2017, 8(1): 40-53.
|
| [47] |
Lin P. The role of the intestinal microbiome in ocular inflammatory disease [J]. Curr Opin Ophthalmol, 2018, 29(3): 261-266.
|
| [48] |
Huang Y, Wang Z, Ma H, et al. Dysbiosis and implication of the gut microbiota in diabetic retinopathy [J]. Front Cell Infect Microbiol, 2021, 11: 646348.
|
| [49] |
Ye P, Zhang X, Xu Y, et al. Alterations of the gut microbiome and metabolome in patients with proliferative diabetic retinopathy [J]. Front Microbiol, 2021, 12: 667632.
|
| [50] |
Beli E, Yan Y, Moldovan L, et al. Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice [J]. Diabetes, 2018, 67(9): 1867-1879.
|